Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer have?
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer has 8,599 citations in the OpenAlex counts ScholarIQ stores.
When was Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer published?
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer has 2015 year in the ScholarIQ index.
What is the open-access status of Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer?
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer?
The DOI for Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer?
The PMID for Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer?
The OpenAlex for Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer is on the source record.